Cecile Brosset, CEO and Co-founder of SonioBurnout among sonographers is becoming an alarming reality, driven by the demanding nature of their work. Every day, they face the emotional burden of delivering difficult news to patients, often with little time to recover before moving on to the next case. Long shifts and high-stress environments only add to the strain, making it harder for them to maintain their well-being. To address this, it’s essential to understand the root causes. The key risk factors contributing to sonographer burnout are as follows:1. Heavy Workload and ExhaustionSonographers are handling an increasing number of exams and tasks each day

AI-Powered Sonio Detect Granted CE Mark. by Fred Pennic 09/16/2024 Leave a Comment. What You Should Know: – Sonio, a medtech company dedicated to women’s and children’s health, announced today that it has received CE marking for its innovative product, Sonio Detect. – The AI-powered software, already available in the United States, is now poised to enhance ultrasound examinations and improve care quality in France and throughout Europe.Sonio’s Mission and MilestonesFounded in 2020 with the mission to improve the health of women and children globally, Sonio specializes in developing cutting-edge AI solutions for obstetric and gynecological ultrasound. The company has achieved several significant milestones, including receiving FDA 510(k) regulatory clearance for Sonio Detect in July 2023 and securing its first U.S. customer, Pediatrix Medical Group, Inc., in February 2024. With the CE mark for Sonio Detect, the company is now ready to broaden its reach and impact in the European market.Sonio Detect: Ensuring High-Quality Ultrasound ExaminationsSonio Detect is designed to elevate the standard of ultrasound examinations by automatically detecting views, anatomical structures, and predefined quality criteria in ultrasound images

Samsung's medical equipment division has completed the acquisition of French AI ultrasound startup Sonio for €86 million. Sonio, founded in 2020, developed an AI assistant to enhance ultrasound scans and recently received FDA approval for Sonio Detect. Despite the acquisition, Sonio will remain an independent company headquartered in France and continue to ensure compatibility with all ultrasound devices. Sonio had previously raised a total of $27.2 million.